echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Prices of 67 drug networks in Jiangsu Province are exposed

    Prices of 67 drug networks in Jiangsu Province are exposed

    • Last Update: 2019-11-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    ▍ finishing: Banxia On November 21, Jiangsu public resources trading platform issued the notice on publicizing the direct online purchase of short drugs 67 drugs were directly online and the online price was announced The notice shows that according to the notice on purchasing short drugs issued by Jiangsu medical insurance bureau, the relevant departments of Jiangsu Province have reviewed the qualification materials declared by the enterprises directly online purchasing short drugs Now, the qualified products directly online purchasing short drugs are publicized, with the public display period from November 21 to November 27, 2019 at 17:00 A total of 67 drugs were directly linked to the Internet, including tetanus antitoxin, 654-2 injection, nicothamide injection, cytarabine hydrochloride for injection, etc., which frequently appeared in the list of drugs in short supply From the published price of the Internet, there are many kinds of prices are still rising to a certain extent For example, by querying the data base of minenet, it can be found that the net price of methotrexate for injection (1.0g) of a pharmaceutical company in Jiangsu Province is 289 yuan, but the price in Heilongjiang Province was only 115.08 yuan; the net price of aminomethylbenzoic acid injection (10ml: 0.1g) of a pharmaceutical company in Jiangsu Province is 22.79 yuan, but the price in Yunnan Province was only 1.99 yuan The public announcement form of direct online purchase products of drugs in short supply in Jiangsu Province is as follows: You will recall that in June this year, during his visit to Hangzhou, Zhejiang Province, the premier of the State Council clearly made two "absolutely not" instructions for the shortage and shortage of commonly used emergency medicine: never cut off the goods, never arbitrarily increase the price Nowadays, the shortage of commonly used medicine and emergency medicine has become one of the hot topics concerned by all walks of life In fact, the prime minister has repeatedly given instructions on first aid and commonly used drugs As early as November 2017, mercaptopurine, an essential drug for the treatment of childhood acute lymphoblastic leukemia, was in short supply and its price increased greatly However, the price of the same imported product was too high The prime minister instructed "special affairs special office" to restore its normal supply as soon as possible At the executive meeting of the State Council on April 3, 2019, the premier also stressed: "we should seriously study the causes of the shortage of drugs, especially to prevent the unreasonable price rise of urgently needed and commonly used drugs, and take effective measures to ensure the supply." In recent years, the prime minister has repeatedly commented on the shortage and price increase of cheap and commonly used drugs, which shows that the state is very firm in its determination to ensure that there is no shortage of commonly used drugs and first-aid drugs.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.